Research programme: sigma 1 receptor antagonists - Neurotech

Drug Profile

Research programme: sigma 1 receptor antagonists - Neurotech

Alternative Names: NP-07; NP-2007

Latest Information Update: 28 Aug 2012

Price : $50

At a glance

  • Originator Neurotech Pharmaceuticals
  • Developer GNT Pharma
  • Class
  • Mechanism of Action Glutamate agonists; Sigma-1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Neuropathic pain; Pain

Most Recent Events

  • 28 Aug 2012 No development reported - Preclinical for Neuropathic pain in South Korea (unspecified route)
  • 28 Aug 2012 No development reported - Preclinical for Pain in South Korea (unspecified route)
  • 22 Aug 2007 Preclinical trials in Neuropathic pain in South Korea (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top